Monkeypox mortality rate - There is a reason for the urgent support of vaccines.

Monkeypox mortality rate - There is a reason for the urgent support of vaccines.

Recently, the monkeypox virus has been spreading globally, causing concern among many people. Monkeypox was previously a disease mainly occurring in specific regions of Africa, but now confirmed cases are emerging across multiple countries beyond borders. In this situation, why are various countries urgently providing vaccines?

First, the mortality rate of monkeypox is noteworthy. Generally, the mortality rate of monkeypox is reported to be between 1% and 10%. This can vary depending on the type of mutated virus and the patient's immune status, but it is certainly not negligible. It can be fatal especially for immunocompromised individuals, children, and the elderly. Therefore, prevention of monkeypox is very important.

For this reason, emergency support for vaccines is being provided. Monkeypox is a virus similar to smallpox, so existing smallpox vaccines are known to be effective. However, the problem is that vaccine supply is insufficient. As global demand for vaccines surges, international cooperation to quickly supply vaccines is urgently needed.

Vaccines are not only essential for preventing the spread of monkeypox but also for protecting high-risk groups and reducing the mortality rate of monkeypox. In areas where infections have already occurred, it is crucial to quickly distribute vaccines to prevent further spread, while in regions where no infections have yet occurred, preparing for vaccination as a preventive measure is important.

Ultimately, the urgent support for the monkeypox vaccine is not just a temporary measure to get through the current crisis. It is a crucial step in responding to global health threats and an essential line of defense to protect people's lives. To reduce the mortality rate of monkeypox and prevent greater damage, the rapid distribution and administration of vaccines are of utmost importance.